AMRX
Price
$19.88
Change
+$0.31 (+1.58%)
Updated
Oct 14, 11:02 AM (EDT)
Capitalization
7.14B
15 days until earnings call
Intraday BUY SELL Signals
SIGA
Price
$3.06
Change
-$0.01 (-0.32%)
Updated
Oct 14, 11:18 AM (EDT)
Capitalization
248.6M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMRX vs SIGA

AMRX vs SIGA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AMRX vs. SIGA commentary
Oct 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and SIGA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AMRX with price predictions
Oct 13, 2026

AMRX in +1.93% Uptrend, advancing for three consecutive days on October 12, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AMRX advanced for three days, in 242 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

AMRX moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AMRX crossed bullishly above the 50-day moving average on September 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.

Bearish Trend Analysis

The 10-day RSI Indicator for AMRX moved out of overbought territory on September 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 33 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 60 cases where AMRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 60%.

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMRX as a result. In 61 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for AMRX turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 28 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

AMRX broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AMRX entered a downward trend on September 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.

The Tickeron Seasonality Score of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. AMRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (217.391) is normal, around the industry mean (43.873). P/E Ratio (42.708) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (1.947) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.899) is also within normal values, averaging (178.797).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for SIGA with price predictions
Oct 13, 2026

SIGA in downward trend: price dove below 50-day moving average on October 13, 2026

SIGA moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 23 of 27 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SIGA as a result. In 73 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for SIGA turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 32 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIGA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for SIGA crossed bullishly above the 50-day moving average on September 25, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +3.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where SIGA advanced for three days, in 232 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

SIGA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 138 of 178 cases where SIGA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.504) is normal, around the industry mean (43.873). P/E Ratio (11.214) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.152). SIGA's Dividend Yield (0.081) is considerably higher than the industry average of (0.005). P/S Ratio (4.161) is also within normal values, averaging (178.797).

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. SIGA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

FUNDAMENTALS RATINGS
AMRX vs SIGA: Fundamental Ratings
AMRX
SIGA
OUTLOOK RATING
1..100
3092
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
8100
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
3663
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
2650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for AMRX (90) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew significantly faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (8) in the Pharmaceuticals Major industry is significantly better than the same rating for SIGA (100) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew significantly faster than SIGA’s over the last 12 months.

SIGA's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as SIGA (63) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to SIGA’s over the last 12 months.

SIGA's P/E Growth Rating (9) in the Pharmaceuticals Other industry is significantly better than the same rating for AMRX (100) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew significantly faster than AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXSIGA
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 8 days ago
69%
Bearish Trend 1 day ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
COMPARISON
Comparison
Oct 14, 2026
Stock price -- (AMRX: $19.57 vs. SIGA: $3.08)
Brand notoriety: AMRX and SIGA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMRX: 64% vs. SIGA: 46%
Market capitalization -- AMRX: $7.14B vs. SIGA: $248.6M
AMRX [@Pharmaceuticals: Generic] is valued at $7.14B. SIGA’s [@Pharmaceuticals: Generic] market capitalization is $248.6M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green while SIGA’s FA Score has 2 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • SIGA’s FA Score: 2 green, 3 red.
According to our system of comparison, SIGA is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 3 TA indicator(s) are bullish while SIGA’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 3 bullish, 7 bearish.
  • SIGA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SIGA is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Generic) experienced а -3.57% price change this week, while SIGA (@Pharmaceuticals: Generic) price change was -6.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.86%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +15.65%.

Reported Earning Dates

AMRX is expected to report earnings on Oct 29, 2026.

SIGA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.86% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
AMRX
Daily Signal:
Gain/Loss:
SIGA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XDEC44.060.06
+0.14%
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - December (XDEC)
UXAP44.690.01
+0.02%
FT Vest U.S. Equity Uncapped Accelerator ETF - April (UXAP)
AMLP52.71N/A
N/A
Alerian MLP ETF (AMLP)
PBOC31.72-0.03
-0.08%
PGIM S&P 500 Buffer 20 ETF - October (PBOC)
ARKX31.44-0.32
-1.01%
ARK Space & Defense Innovation ETF (ARKX)

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with AMPH. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then AMPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-2.30%
AMPH - AMRX
46%
Loosely correlated
-2.65%
VTRS - AMRX
43%
Loosely correlated
-1.65%
ANIP - AMRX
39%
Loosely correlated
-3.74%
TEVA - AMRX
38%
Loosely correlated
+0.19%
COLL - AMRX
35%
Loosely correlated
-2.36%
More

SIGA and

Correlation & Price change

A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
-2.53%
EBS - SIGA
33%
Poorly correlated
-1.00%
ETON - SIGA
30%
Poorly correlated
-3.48%
AYTU - SIGA
27%
Poorly correlated
+1.02%
AMRX - SIGA
27%
Poorly correlated
-2.30%
XERS - SIGA
25%
Poorly correlated
-2.49%
More